Mix and match = better patient satisfaction

Article

Mixing and matching the ReZoom (AMO) and Tecnis (AMO) multifocal intraocular lenses (IOLs) produces enhanced visual outcomes and patient satisfaction.

Mixing and matching the ReZoom (AMO) and Tecnis (AMO) multifocal intraocular lenses (IOLs) produces enhanced visual outcomes and patient satisfaction, according to Baha Toygar and colleagues from the Dunya Eye Hospital, Istanbul, Turkey.

In a concurrent case series, 11 refractive lens exchange (RLE) patients and three cataract patients were bilaterally implanted with ReZoom in the dominant eye and Tecnis in the fellow eye. One subject with high hyperopia underwent a piggyback IOL implantation. The target refraction for both multifocal IOLs was emmetropia.

At six-month follow-up, mean postoperative spherical equivalent (SE) was -0.11±0.47 D. Monocular uncorrected and best corrected distance visual acuity (VA) was 0.78±0.21 and 0.95±0.16, respectively. All patients, except for the patient receiving the piggyback implantation, could read 20/20 binocularly. Eighty-two percent of subjects achieved a near uncorrected VA of J2 or better and, when tested binocularly without correction, 100% of patients could read J2 or better, including 65% who achieved J1 or better. None of the patients reported halos or glare.

The researchers concluded from their study that the combination of the two lenses leads to enhanced visual outcomes and patient satisfaction.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.